Last reviewed · How we verify

Mannitol Inhalation Kit — Competitive Intelligence Brief

Mannitol Inhalation Kit (Mannitol Inhalation Kit) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Osmotic agent / Airway clearance therapy. Area: Respiratory / Pulmonology.

marketed Osmotic agent / Airway clearance therapy Respiratory / Pulmonology Small molecule Live · refreshed every 30 min

Target snapshot

Mannitol Inhalation Kit (Mannitol Inhalation Kit) — Dr. Diane Lougheed. Mannitol inhalation acts as an osmotic agent that draws fluid into the airways to hydrate secretions and promote airway clearance.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Mannitol Inhalation Kit TARGET Mannitol Inhalation Kit Dr. Diane Lougheed marketed Osmotic agent / Airway clearance therapy

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Osmotic agent / Airway clearance therapy class)

  1. Dr. Diane Lougheed · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Mannitol Inhalation Kit — Competitive Intelligence Brief. https://druglandscape.com/ci/mannitol-inhalation-kit. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: